Key Insights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed with results

Key Signals

3Total

Not Applicable (2)

P 1 (1)

Terminated1

Unknown1

Recruiting1

Withdrawn1

Clinical Trials (4)

Showing 4 of 4 trials

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

Registry Platform Ovarian and Endometrial Cancer

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Showing all 4 trials